FT : The Vix indicator of the time to buy

The Vix indicator of the time to buy
A rise in the equity market’s fear gauge is usually a signal of a rally to come

It is sometimes called the market’s fear gauge but investors should take a positive cue when the CBOE Volatility index rises.

When the Vix rises above the key threshold of 30 — as it did most recently on March 30 — it indicates a degree of uncertainty in markets that might suggest reining in equity positions to some. A historical analysis signals just the opposite.

We have examined the 724 instances in which the Vix closed above the 30 mark over the past 30 years, excluding the two most recent instances. Investors who bought the S&P 500 when the Vix closed above 30 enjoyed positive returns 70 to 83 per cent of the time, with average gains of 12.4 per cent in six months.

The pattern is familiar to even a casual market observer. Fear overshoots, forced selling creates dislocations and prices subsequently rebound, mean-reverting.

That pattern has been reflected in recent moves in the Vix, a real-time measure of expected 30-day volatility in US equities calculated from options pricing.

After peaking at more than 31.65 on March 27 amid increased tensions between the US and Iran and worries over the future path of AI, it has since fallen back nearly a third to 20.14. While a recent sentiment survey of US investors showed they were the most bearish since the period post “liberation day” announcement of US tariffs last year, the S&P 500 has rallied about 7 per cent from the March 27 close.

What do we find when we examine prior episodes of the Vix over 30? The average returns are decidedly positive (2.4 per cent after one month, 6.6 per cent after three months and 12.4 per cent after six months). But those averages obscure a wide range of outcomes. The worst one-month return was minus 27.7 per cent, while the best was a positive 26.6 per cent. At six months, the range extends from a fall of 37.9 per cent to a rise of 52.7 per cent.

For an investor looking to buy the S&P 500 when the Vix exceeds 30, the time horizon makes a meaningful difference. In 509 of 724 instances we examined — 70 per cent of the time — investors saw a positive return at the one-month mark. At the three-month point, the percentage rises to 76 per cent, and at six months, it reaches 83 per cent. Once again, patience is rewarded — a market cliché that has the added advantage of also being true.


In the current market environment, technical signals appear consistent with prior episodes of the Vix over 30 that preceded recoveries. Market fundamentals look solid as well, assuming that the Middle East conflict eases within a reasonable timeframe and the supply shock to the economy proves to be contained. They are big “ifs” but we see a bright outlook for corporate profits.

The approaching first-quarter earnings season will serve as a test. Will top-line revenues reflect healthy consumer demand? Will companies’ forward guidance suggest that profit margins are coming under pressure? Consensus estimates project about 12 per cent S&P 500 EPS growth in the first quarter, which would mark the sixth consecutive quarter of double-digit earnings growth. That may prove optimistic, but we do think investors will broadly cheer first-quarter earnings results.

And stock valuations look attractive with a recent drop in price-earnings multiples to levels below those seen in the wake of “liberation day” and the five-year average. The multiple for the S&P 500, which is basically flat year to date, is 20.15 times below the one-year, three-year and five-year average.

Equity investors discount the future. As they worry more about growing risk, anticipating margin pressure and slowing economic momentum, they drive valuations lower well before earning growth actually declines. That’s why we often see price-earnings multiples trough on peak profits.

When investor worries prove unfounded — when the bad news does not happen — equity markets recalibrate. Typically they mean revert. Earnings confirm corporate resilience and forward multiples expand.

Market analysts speak of the equity risk premium for a reason. Buying equities is inherently risky and there is no “perfect” time to invest in the S&P 500.

But the data over 30 years sends a clear message: the odds overwhelmingly favour the buyer when the Vix is above 30. Expectations of volatility have calmed recently but investors should take note if uncertainty starts to pick up once more.

>>> What to look at today - 14th of April 2026

Stocks rose and oil declined after President Donald Trump signaled a willingness to resume talks with Iran, boosting expectations for a potential deal that will ease tensions in the Middle East. The MSCI All Country World Index climbed 0.4%, heading for an eighth day of gains that would be its longest winning streak since September. Asian shares followed Wall Street higher, led by technology firms, with the regional gauge rising 1.7% on optimism that easing tensions will lower oil prices and support economic growth. European shares were also set for a stronger open. Brent crude fell 1.5% to $97.90 a barrel on signs Washington and Tehran may revive peace talks even after the start of a US blockade of the Strait of Hormuz. The dollar weakened against most of its Group-of-10 peers, while Treasuries edged higher as lower oil prices eased inflation concerns. Stocks are rallying as investors focused on signs that US-Iran talks are ongoing and may gain traction, lifting confidence in a potential deal despite the blockade of the Strait of Hormuz. The US decision to blockade the waterway is also seen as a targeted measure to curb Iran’s oil revenues, while paving the way for securing shipping routes, reinforcing expectations that energy flows may eventually resume. Trump ordered the blockade of the Strait of Hormuz after negotiations in Islamabad over the weekend had failed to produce any deal. Even amid the latest escalation, the US and Iran are discussing another round of talks, according to people familiar with the matter. The goal is to hold fresh discussions before a two-week ceasefire announced April 7 expires next week, they said.  Treasuries rose with the yield on the 10-year falling one basis point to 4.28% as cheaper oil helps contain inflation. Gold rebounded after two days of losses to trade around $4,775 an ounce, while Bitcoin climbed to about $74,400. Copper rose to the highest level in more than a month. Still, the technology sector led the focus, with MSCI’s Asia Pacific tech gauge jumping 4.2% and companies such as Kioxia Holdings Corp. surging 15% in Tokyo. Taiwan’s Taiex Index rose to a record as investors returned to the AI theme — seen as less impacted by the war in Iran. South Korea’s Kospi, a poster child for AI investments, surged 3.4% as sentiment improved with the S&P 500 Index erasing all losses triggered by the Iran conflict. Traders are also focused on the first-quarter earnings season, which got off to a mixed start on Monday, as they look for an early read on the financial health of corporate America. JPMorgan Chase & Co., Wells Fargo & Co. and Citigroup Inc. are due to report Tuesday as the Middle East conflict weighs on the outlook. Goldman Sachs Group Inc. shares slipped 1.9% Monday following its results. Meanwhile, HSBC Holdings Plc Chief Executive Officer Georges Elhedery said the conflict in the Middle East and broader “uncertainties” are beginning to dent client confidence as investors navigate an increasingly volatile global landscape. US After Hours BE +12.7% after expanding its strategic partnership with Oracle (ORCL +1%); CRDO +9% on acquisition of DustPhotonics; FBK -2.9% lower on earnings.

Nikkei +2.29% Hang Seng +0.43% CSI +0.84% Shanghai +0.55% Shenzen +1%

Eur$ 1.1765 CNH 6.8143 CNY 6.8179 JPY 159.03 GBP 1.3516 CHF 0.7833 RUB 76.1644 TRY 44.7165 WTI$ 96.19 -2.31% Gold 4,765 +0.65% BTC 74,384 +1.62% ETH 2,364 +4.89%

S&P +0.03% Nasdaq +0.13% EuroStoxx +0.49% FTSE +0.03% Dax +0.66% SMI +0.36%

Macro :
- Citi Upgrades US Stocks, Cuts EM on Iran War Resolution Hopes
- US-Sanctioned Tanker Tests Trump Blockade With Hormuz Transit
- Oil Declines as US, Iran Weigh More Talks With Blockade in Place

Keep an eye on :
- AMZN US : Amazon Is Said to Near Globalstar Deal in Push to Rival Starlink
- ANTO LN : Antofagasta Signals Interest in Joining Argentina’s Copper Rush
- ASML NA : Dutch PM to Discuss ASML Export Curbs with Trump: ANP
- 3750 HK : CATL Is Said to Consider Up to $5 Billion Share Sale in HK
- COTN SW : Comet 1Q Net Sales CHF106.3M Vs. CHF111.2M Y/y
- CRDO US : Credo Rises on Deal to Buy DustPhotonics for Cash and Shares
- DELL US : Nvidia Denies Acquisition Rumor That Sparked Dell, HP Rise
- ERF FP : Eurofins to Sell Electrical & Electronic Testing Business, UL Solutions to Buy Eurofins’ Electrical & Electronics Business
- FDX US : FedEx CFO Dietrich to Step Down After Spinoff of Freight Unit
- GALP PL : Galp 1Q Refining Margin Beats Estimates
- GIVN SW : Givaudan 1Q Sales Meet Estimates
- GS US : Goldman, Ardian Bought CIC’s $1 Billion US Private Equity Stake
- Hemab IPO : Danish Drugmaker Hemab Plans to IPO in the US, MedWatch Reports
- KURN SW : Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
- MC FP : LVMH 1Q Fashion & Leather Goods Organic Sales Miss Estimates
- MAERSHB DC : Maersk Issues Middle East Ops Update Acknowledging Volatility
- NEM GY : Nemetschek Strikes Deal to Acquire Thoma Software Firm HCSS
- 7201 JP : Nissan to Slash 20% of Models in Espinosa’s Turnaround Plan
- BMPS IM : Vanguard Seen Backing Paschi Board’s Proposed Slate: Ansa
- PIRC IM : Pirelli Holder Sinochem Calls Italy Restrictions Discriminatory
- PPGN SW : PolyPeptide Is Conducting Review of Potential Strategic Options
- PUB FP : Publicis 1Q Organic Revenue Beats Estimates
- SENS SW : Sensirion Confirms Medium-Term Guidance
- SIKA SW : Sika 1Q Sales Beat Estimates
- Space X IPO : Starlink, Televisa’s Bestel Sign Satellite Internet Deal: El CEO
- Space X IPO : SpaceX’s Starlink Rev Rose 50% to $11.4B in 2025: Information
- SYRE US : Spyre Is Said to Seek Pricing Share Sale on Tuesday After Close
- SAX GY : I Squared, Blackstone Said to Mull Joint Bid for Ströer Unit
- TVTX US : Travere Therapeutics Gets FDA Approval For FSGS Drug Filspari

>>> Europe : Brokers Upgrades & Downgrades - 14th of April 2026

>>> Up
* ACS Raised to Overweight at Morgan Stanley; PT 150 euros
* Alm Brand Raised to Buy at Jyske Bank; PT 18.50 kroner
* Biogen Raised to Overweight at Piper Sandler; PT $214 (1)
* Continental Raised to Overweight at Barclays; PT 72 euros
* Eastman Chemical Raised to Overweight at JPMorgan; PT $80
* Ford Raised to Buy at UBS; PT $15
* Glencore Raised to Buy at HSBC; PT 620 pence
* Michelin Raised to Equal-Weight at Barclays; PT 30 euros
* Naturgy Raised to Overweight at JPMorgan; PT 30.50 euros
* Netcompany Price Target Raised to DKK 435 from DKK 410 by Nordea
* PhotoCure Raised to Buy at ABG; PT 80 kroner
* Spyre Therapeutics Inc PT Raised to $106 from $49 at Leerink
* Spyre Therapeutics Inc PT Raised to $85 from $47 at Jefferies
* Standard Chartered Raised to Outperform at BNP Paribas
* Standard Chartered ADRs Raised to Outperform at BNP Paribas
* Temenos Raised to Buy at Citi; PT 90 Swiss francs
* TGS Raised to Neutral at SB1 Markets; PT 110 kroner
* Var Energi Price Target Raised to NOK 52 from NOK 38 by Nordea

>>> Down
* Aixtron Cut to Hold at Deutsche Bank; PT 38 euros
* Barclays Cut to Neutral at BNP Paribas; PT 485 pence
* Barclays ADRs Cut to Neutral at BNP Paribas; PT $26
* Barratt Redrow Cut to Equal-Weight at Morgan Stanley
* Berkeley Cut to Underweight at Morgan Stanley; PT 2,990 pence
* Elia Group Cut to Neutral at Citi; PT 141 euros
* EQT Cut to Neutral at Citi; PT 325 kronor
* GE Vernova Cut to Sell at Punto Casa de Bolsa; PT $839
* HSBC ADRs Cut to Neutral at BNP Paribas; PT $97
* HSBC Cut to Neutral at BNP Paribas; PT 1,450 pence
* Nexi Cut to Neutral at Goldman; PT 3.50 euros
* Nexi Cut to Neutral at Citi; PT 3.40 euros
* Orthex Cut to Reduce at Inderes; PT 5 euros
* Partners Group Cut to Neutral at Citi; PT 940 Swiss francs
* Secure Waste Cut to Sector Perform at Peters & Co; PT C$23
* Tikehau Capital Cut to Neutral at Citi; PT 18 euros
* Worldline Cut to Sell at Goldman; PT 23 euro cents

>>> Initiation
* Airbus Rated New Neutral at BNP Paribas; PT 190 euros
* Campbell's Rated New Neutral at BTIG
* Conagra Rated New Neutral at BTIG
* General Mills Rated New Neutral at BTIG
* Guardian Metal Resources Rated New Outperform at BMO
* Hershey Rated New Neutral at BTIG
* Iforex Financial Trading Rated New Corporate at Shore Capital
* Kraft Heinz Rated New Neutral at BTIG
* Mondelez Rated New Buy at BTIG; PT $70
* MTU Aero Rated New Outperform at BNP Paribas; PT 410 euros
* Safran Rated New Neutral at BNP Paribas; PT 330 euros
* Simply Good Foods Rated New Neutral at BTIG

>>> Call
* Citi Upgrades US Stocks, Cuts EM on Iran War Resolution Hopes

>>> Stoxx 600 Pre-Market Indications

  • Sika (SIKA TH) +5.4%
    • Sika 1Q Sales Beat Estimates
  • Thyssenkrupp (TKA TH) +2.3%
  • BE Semiconductor (BSI TH) +2.2%
    • BE Semiconductor Price Target Raised to EUR 279 from EUR 238 by Bank of America
  • Continental (CON TH) +2.2%
  • MTU Aero (MTX TH) +2%
  • FlatexDEGIRO (FTK TH) +1.9%
  • Nokia (NOA3 TH) +1.9%
  • ASML (ASME TH) +1.5%
  • Naturgy (GAN TH) +1.4%
  • Porsche (P911 TH) +1.3%
  • Vestas (VWSB TH) -1.1%
  • BP (BPE5 TH) -1.7%
  • Repsol (REP TH) -1.9%
  • Equinor (DNQ TH) -2%
  • Eni (ENI TH) -2.1%
  • LVMH (MOH TH) -2.4%
    • LVMH Sales Disappoint as Middle East War Crimps Dior Demand

>>> TradeGate Pre-Market Indications

DAX:
  • Continental (CON TH) +2.7%
    • Continental Raised to Overweight at Barclays; PT 72 euros
  • Infineon (IFX TH) +1.3%
  • Porsche SE (PAH3 TH) +1.3%
  • Deutsche Bank (DBK TH) +1.2%
  • Rheinmetall (RHM TH) +1.2%
MDAX:
  • Thyssenkrupp (TKA TH) +2.3%
  • FlatexDEGIRO (FTK TH) +1.9%
  • Schaeffler (SHA0 TH) +1.4%
  • Porsche (P911 TH) +1.4%
  • AUTO1 (AG1 TH) +1.4%
SDAX:
  • Tonies SE (TNIE TH) +5.9%
  • Heidelberger Druck (HDD TH) +5.1%
  • Kontron (KTN TH) +1.7%
  • Evotec (EVT TH) +1.1%
  • Wacker Neuson (WAC TH) +0.8%
  • Mutares (MUX TH) +0.8%
  • TeamViewer (TMV TH) +0.7%

>>> US After Hours Summary: BE +12.7% after expanding its strategic partnership

After Hours Summary: BE +12.7% after expanding its strategic partnership with Oracle (ORCL +1%); CRDO +9% on acquisition of DustPhotonics; FBK -2.9% lower on earnings

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: None

Companies trading higher in after hours in reaction to news: SANA +24% (strategic collaboration with Mayo Clinic), BE +12.7% (expands strategic partnership with Oracle to deploy up to 2.8 GW), CRDO +9% (to acquire DustPhotonics in cash and stock transaction), JACK +3.7% (appoints new independent director), KDP +1.7% (results of post-closing acceptance period for offer for JDE Peet's), ORCL +1% (BE expands strategic partnership with Oracle to deploy up to 2.8 GW), EYPT +0.6% (investor updates in presentation), SEI +0.5% (stock offering by selling shareholders), IONQ +0.4% (expands QLab collaboration with University of Maryland), RZLV +0.3% (to host call to discuss combination with CMRC), GNK +0.2% (issues statement regarding Diana Shipping's (DSX) letter to shareholders), AB +0.1% (reports March 2026 AUM), FDX +0.1% (CFO to step down; reaffirms FY26 guidance and 2029 financial targets)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: FBK -2.9%

Companies trading lower in after hours in reaction to news: ALLO -5.6% (stock offering), SHAZ -2.8% (accelerated receipt of remaining consideration from sale of 50% ownership in Texas critical data centers joint venture), SYRE -2.3% (terminated prospectus relating sale of common stock in ATM offering; announces $300 mln common stock offering), ATRO -1.9% (launches Qi2 wireless charging module), KZIA -1.8% (expands oncology platform with first-in-class SETDB1 inhibitor drug development platform), WBTN -1.3% (new global leadership structure), RVMD -1.2% (stock and convertible notes offering), FANG -0.5% (realized prices and derivative activity for Q1), INFQ -0.3% (to convene Colorado quantum industry leaders to accelerate commercialization), PRU -0.2% (recommends shareholders reject mini-tender offer from Potemkin Limited), GD -0.2% (awarded a $183.2 mln Navy contract), CVX -0.1% (agreed to an asset swap with Petroleos de Venezuela and subsidiaries of PDVSA)

L'Informe : Orange, Free and Bouygues Telecom Finalise a New Bid for SFR

Orange, Free and Bouygues Telecom Finalise a New Bid for SFR
An improved offer is expected to be submitted within the coming weeks. Several legal hurdles have been cleared, but the proposed price remains the critical sticking point.
Emmanuel Paquette, Jamal Henni — Published: 13/04/2026 at 15:59

"We've entered injury time." For the head of one of the four telecoms operators, the clock is ticking to acquire SFR. After a first rejection last October, the leaders of the consortium made up of Orange, Bouygues Telecom and Free are finalising their discussions to submit a higher new offer, l'Informé has learned.
"It's a matter of weeks before we know whether we go ahead or not," says one of the suitors. Orange wants to complete the acquisition of MasOrange in Spain before the end of the first half, a transaction that will alter the structure of its revenues outside France. After that, the acquisition of SFR would likely be reviewed by European competition authorities rather than French ones.
Several obstacles have already been cleared. For a long time, the parties disagreed on the structure of the transaction: should SFR be sold as a single entity, or broken up, with each acquirer taking only the business lines that interest them? In the first scenario, SFR would ultimately be owned by the trio of buyers; in the second, it would become an empty shell still in Patrick Drahi's hands. An agreement acceptable to Patrick Drahi has reportedly been reached on this seemingly technical point, which conceals a major issue: who will ultimately bear SFR's liabilities, notably ongoing litigation and the associated financial risks?
These include €1.1 billion in tax reassessments arising from various VAT manoeuvres, as well as a series of disputes that SFR has provisioned at €196 million. Furthermore, the three acquirers had feared uncovering skeletons in the closet linked to alleged misconduct by Patrick Drahi's associate, Armando Pereira, who is under formal investigation by Portuguese justice for money laundering and corruption. Drahi has, however, taken care to settle a number of sensitive files in recent months.

The Price Remains the Central Issue
The main sticking point is obviously the price, particularly for Bouygues Telecom, which stands to take on the largest share of assets. In October, the trio had offered €17 billion (with Bouygues's subsidiary paying 43%) for most of the assets, bringing the total valuation to €21 billion. That figure was insufficient for Patrick Drahi, who has implicitly set a floor price of €23.6 billion, above which creditor approval would no longer be required to close the deal.
Since then, the trio has been working on a higher offer covering a broader scope. Yet SFR's representatives — notably Dexter Goei and Malo Corbin — appeared to walk away from talks a few weeks ago before backtracking. "They are very tough negotiators, even though they have the most to lose," one of the buyers noted with surprise.
That is not entirely accurate. If talks collapse, buyers Orange and Bouygues would suffer on the stock market, as their share prices have been buoyed for months by the prospect of consolidation.

Fallback Options for the Seller
On the seller's side, several options would remain open in the event of failure. First, a break-up sale already tested with investment funds and alternative telecoms operators. Potential buyers have already come forward for SFR's infrastructure network (NetCo) or its enterprise division (SFR Business). "And the consortium members, once failure is confirmed, could themselves bid individually for certain assets — and end up competing against each other," one insider noted.
In theory, Patrick Drahi could still attempt a full sale to a foreign buyer — names such as Etisalat, STC and KKR have been mentioned. However, any new entrant would offer a significantly lower price, as such a deal would not reduce the number of operators and would generate no synergies (higher prices, lower investment, job cuts). Last October, JP Morgan analysts estimated that SFR was worth €20.5 billion in a sale to its three rivals, but only €16.1 billion without consolidation — equivalent to 5x 2027 EBITDA, the sector average.
A final option would be to abandon the sale altogether. But that appears increasingly unrealistic. SFR still carries €16 billion of debt, and its commercial performance continues to deteriorate. Revenue fell 9.3% in the third quarter to €2.26 billion, while EBITDA declined 11.4% to €764 million. More worryingly, in its latest note, Standard & Poor's predicted that EBITDA would continue to fall through 2026, that free operating cash flows would remain negative until 2027, and that the operator's financial structure was not viable in the long term.
None of the four companies contacted wished to comment.

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • IDYA +29.8%, TLX +8.6%, LEG +8.5%, USO +7.1%, PLBY +5.7%, KGEI +5.6%, XOM +2.5%, BORR +2.2%, CVX +2.1%, BKR +1.4%, SNDK +1.4%, SHEL +1.1%, PRTC +1.1%, BP +0.9%
  • Gapping down:
    • BNTX -2.6%, STLA -2.5%, SGI -1.7%, SNY -1.1%

>>> Europe : Brokers Upgrades & Downgrades - 13th of April 2026 V3(++)

>>> Up
* ABB Raised to Equal-Weight at Barclays; PT 67 Swiss francs
* Atrium Ljungberg Raised to Buy at Kepler Cheuvreux; PT 34 kronor (++)
* Applied Materials PT Raised to $500 from $450 at Wolfe
* Bravida Price Target Raised to SEK 130 from SEK 113 by Danske Bank
* CoreWeave Raised to Outperform at Macquarie; PT $125
* Fluidra Raised to Buy at JB Capital Markets; PT 25.40 euros
* Instalco Price Target Raised to SEK 45 from SEK 40 by Danske Bank
* Kone Raised to Buy at Danske Bank Markets; PT 71 euros
* Norske Skog Raised to Buy at SB1 Markets; PT 50 kroner
* Ryanair Raised to Outperform at Bernstein; PT 77 euros (+)
* Schindler Raised to Neutral at Goldman; PT 272 Swiss francs
* SKF Raised to Buy at Nordea; PT 290 kronor
* Starbucks Raised to Hold at Jefferies; PT $92
* Swedbank Raised to Buy at Deutsche Bank; PT 382 kronor (+)
* T-Mobile Raised to Overweight at KeyBanc; PT $260
* TT Electronics Raised to Buy at Berenberg; PT 150 pence (+)
* Vaisala Price Target Raised to EUR 53 from EUR 51 by SEB

>>> Down
* ABB Cut to Neutral at Citi; PT 76 Swiss francs
* AB Foods Cut to Underperform at RBC; PT 1,850 pence
* Aixtron Cut to Hold at Deutsche Bank; PT 38 euros (+)
* Austrian Post Cut to Underperform at Oddo BHF; PT 30 euros
* Autoliv GDRs Cut to Hold at ABG; PT 1,125 kronor
* Avanza Cut to Neutral at SB1 Markets; PT 405 kronor
* Bossard Cut to Hold at Research Partners; PT 183 Swiss francs
* EasyJet Cut to Market Perform at Bernstein; PT 425 pence (+)
* Epiroc Cut to Hold at ABG; PT 265 kronor
* Essentra Cut to Hold at Deutsche Bank; PT 100 pence (+)
* Essity Price Target Cut to SEK 301 from SEK 310 by SEB
* Hostelworld Rated New Buy at Berenberg; PT 171 pence (+)
* Industrivarden Cut to Sell at SEB Equities; PT 484 kronor
* Kering Cut to Equal-Weight at Morgan Stanley; PT 320 euros
* Legrand Cut to Equal-Weight at Barclays; PT 144 euros
* Microsoft PT Cut to $556 from $659 at BNP Paribas
* Nemetschek Cut to Sell at UBS; PT 56 euros
* Nike Cut to Hold at HSBC; PT $48 (+)
* Nokia Cut to Hold at Nordea
* Oshkosh Cut to Neutral at Citi; PT $170 (++)
* Repsol Cut to Underweight at Banco Sabadell; PT 23.34 euros
* Rexel Cut to Underweight at Barclays; PT 29 euros
* Rotork Cut to Equal-Weight at Barclays; PT 355 pence
* RS Group Cut to Hold at Deutsche Bank; PT 700 pence (+)
* Sandvik Cut to Neutral at Citi; PT 405 kronor
* SEB Price Target Cut to SEK 180 from SEK 195 by Nordea
* Singulus Tech Cut to Hold at mwb research AG; PT 4.20 euros (++)
* STMicro Cut to Accumulate at Banca Akros (ESN); PT 35 euros (++)
* Verbund Downgraded to Underperform from Neutral by Bank of America
* Volvo Cut to Hold at Pareto Securities; PT 350 kronor
* WH Smith Cut to Sector Perform at RBC; PT 650 pence
* Wizz Air Cut to Market Perform at Bernstein; PT 1,300 pence (+)

>>> Initiation
* Aalberts Reinstated Neutral at BNP Paribas; PT 32 euros (+)
* Antofagasta Reinstated Buy at William O'Neil
* Arribatec Group ASA Rated New Buy at Pareto Securities
* Assa Abloy Rated New Inline at Evercore ISI; PT 395 kronor (++)
* Beijer Ref Rated New Underperform at BNP Paribas; PT 110 kronor (+)
* Belimo Reinstated Neutral at BNP Paribas; PT 700 Swiss francs (+)
* Coherent Corp Rated New Buy at William O'Neil
* Credo Technology Rated New Buy at Jefferies; PT $175
* Holcim Resumed Buy at Deutsche Bank; PT 85 Swiss francs (+)
* Johnson Controls Rated New Inline at Evercore ISI; PT $155 (++)
* Kone Rated New Inline at Evercore ISI; PT 60 euros (++)
* Legrand Rated New Inline at Evercore ISI; PT 160 euros (++)
* LU-VE Reinstated Outperform at BNP Paribas; PT 55 euros (+)
* NIBE Industrier Reinstated Outperform at BNP Paribas
* Oncoinvent ASA Rated New Buy at ABG; PT 70 kroner
* One Health Group Rated New Buy at Singer Capital Markets (++)
* Pandora Reinstated Hold at Kepler Cheuvreux; PT 525 kroner (++)
* Tempus AI Rated New Underperform at Jefferies; PT $35
* UPM-Kymmene Rated New Buy at SB1 Markets; PT 38 euros
* Wartsila Reinstated Buy at William O'Neil

>>> Call
* AB Foods Cut to Underperform at RBC on Primark Earnings Risk (+)
* Pareto Global Adds Autotrader Group PLC, Exits Compass Group
* Morgan Stanley’s Wilson Would Add Risk on S&P 500 Pullback (++)
* Nemetschek Falls to 2023 Low as UBS Cuts to Sell on Sales Risk (++)
* Schindler Raised to Neutral at Goldman After Underperformance (++)
* T-Mobile Raised to Overweight at KeyBanc on Valuation Upside (++)
* Vallourec Climbs as CIC Lifts PT on Promising New Opportunities (++)
* WH Smith Cut to Sector Perform as RBC Sees Passenger Pressure (+)
* Wickes Drops as Panmure Liberum Downgrades on Ambitious Forecast (++)

FT : Von der Leyen aide to lead powerful EU competition directorate

Von der Leyen aide to lead powerful EU competition directorate
Anthony Whelan appointment signals European Commission’s willingness to use antitrust powers to help businesses scale up

Anthony Whelan, a former aide of European Commission president Ursula von der Leyen, will lead the powerful competition directorate, according to two officials briefed on the decision.

The job was temporarily filled since the departure of Olivier Guersent last summer and had become emblematic for ideological splits about the future of EU competition policy — and the extent to which it can be used to help the bloc’s companies compete with US and Chinese rivals.

The Whelan appointment, given his proximity to von der Leyen, suggests he may back the Commission president in her pursuit of leveraging competition policy to help European companies scale up.

Whelan is an Irish official who is steeped in tech policy. After advising von der Leyen on digital and competition issues, he led the competition directorate’s state aid department.

Brussels is currently revising its merger guidelines, a policy discussion which has become symbolic for the opposing visions of von der Leyen and EU competition chief Teresa Ribera.

While von der Leyen wants to allow more scale to increase the bloc’s competitiveness, Ribera has made clear she does not want competitiveness to be the pretext for allowing market concentration. A Spanish socialist, Ribera instead wants the Commission to focus more on integrating the single market.